RAPID ANTIGEN SCREENING PROGRAM TERMS OF USE AGREEMENT – ELIGIBLE BUSINESSRapid Antigen Screening Program • May 28th, 2021 • Ontario
Contract Type FiledMay 28th, 2021 JurisdictionTo assist in facilitating private sector workplace screening, the Chamber has partnered with the Town of Whitby, the federal and provincial governments to assist in the distribution of approved COVID-19 Rapid Testing Devices, which currently include the Abbott Panbio™ Rapid Antigen Test and the BD Veritor™ System (collectively the “Devices”) to private businesses seeking to implement Point of Care screening (“Rapid Antigen Screening”) at their workplaces.
TERMS OF USE AGREEMENT – ELIGIBLE BUSINESSRapid Antigen Screening Program • April 6th, 2022
Contract Type FiledApril 6th, 2022• To assist in facilitating private sector workplace screening, the Chamber has partnered with the federal and provincial governments to assist in the distribution of approved COVID-19 Rapid Testing Devices, (collectively the “Devices”) to private businesses seeking to implement Point of Care screening (“Rapid Antigen Screening”) at their workplaces.
TERMS OF USE AGREEMENT – ELIGIBLE BUSINESSRapid Antigen Screening Program • July 19th, 2021 • Ontario
Contract Type FiledJuly 19th, 2021 Jurisdiction• To assist in facilitating private sector workplace screening, the Board of Trade has partnered with the Distributor and the federal and provincial governments to assist in the distribution of approved COVID-19 Rapid Testing Devices, which currently include the Abbott Panbio™ Rapid Antigen Test and the BD Veritor™ System (collectively the “Devices”) to private businesses seeking to implement Point of Care screening (“Rapid Antigen Screening”) at their workplaces.
TERMS OF USE AGREEMENT – ELIGIBLE BUSINESSRapid Antigen Screening Program • June 9th, 2021
Contract Type FiledJune 9th, 2021• To assist in facilitating private sector workplace screening, the Chamber has partnered with the federal and provincial governments to assist in the distribution of approved COVID-19 Rapid Testing Devices, which currently include the Abbott Panbio™ Rapid Antigen Test and the BD Veritor™ System (collectively the “Devices”) to private businesses seeking to implement Point of Care screening (“Rapid Antigen Screening”) at their workplaces.